Factors such as RT dosimetric parameters, the role of tumor-infiltrating lymphocytes (TILs), and the impact of levels of PD-L1 expression may aid in our understanding of who might be at higher risk for certain reactions and hence provide optimal prevention and management of this subset of irAEs. This evidence concerns the gene CD274 and neoplasm.